Share This Page
Drug Price Trends for NDC 45802-0042
✉ Email this page to a colleague
Average Pharmacy Cost for 45802-0042
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| CLINDESSE 2% VAGINAL CREAM | 45802-0042-01 | 26.70169 | GM | 2025-12-17 |
| CLINDESSE 2% VAGINAL CREAM | 45802-0042-01 | 26.70842 | GM | 2025-11-19 |
| CLINDESSE 2% VAGINAL CREAM | 45802-0042-01 | 26.71900 | GM | 2025-10-22 |
| CLINDESSE 2% VAGINAL CREAM | 45802-0042-01 | 26.73053 | GM | 2025-09-17 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 45802-0042
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 45802-0042
Introduction
The pharmaceutical landscape for NDC 45802-0042, a specific drug identified through the National Drug Code (NDC) system, warrants a comprehensive market analysis and price projection due to its strategic positioning within its therapeutic category. As a key component influencing healthcare expenditures, understanding factors such as market demand, competitive dynamics, regulatory influences, and pricing trends is vital for stakeholders ranging from manufacturers to healthcare providers and payers.
Product Overview and Therapeutic Landscape
NDC 45802-0042 corresponds to [Insert Drug Name], indicated primarily for [insert primary indications]. Its mechanism involves [summarize mechanism of action], positioning it as a [e.g., first-in-class, biosimilar, branded] agent within the [therapeutic class] category. The drug's clinical profile highlights advantages such as [e.g., efficacy, safety, convenience], which influence demand dynamics.
Current treatment paradigms favor [e.g., long-term management, combination therapy], with an increasing adoption driven by [e.g., recent approval, positive clinical trial results, evolving guidelines]. Its role is reinforced by expanding indications and an aging population, which collectively support market growth.
Market Size and Demand Drivers
Current Market Size
Based on recent data from IQVIA[1] and other industry reports[2], the total market for drugs within this class approximates $X billion, with NDC 45802-0042 capturing [Y]% of this space. The prevalence of [indication] currently affects [number] million patients in the U.S., with global figures projected at [number].
Demand Drivers
- Patient Demographics: Rising incidence of [disease] among senior populations boosts treatment needs.
- Clinical Adoption: Clinical guidelines increasingly endorse [drug name] due to demonstrable benefits.
- Reimbursement Policies: Favorable reimbursement codes and rising insurance coverage expand access.
- Orphan and Specialty Status: Eligibility for special designations (e.g., orphan drug exclusivity) enhances market exclusivity prospects.
Competitive Dynamics
Key Competitors
The competitive landscape comprises:
- Branded alternatives: [Major competitors], which hold [market share]% collectively.
- Biosimilars/generics: Entry of biosimilars or generics could pressure pricing post-patent expiry.
- Emerging therapies: Novel agents with superior efficacy or administration routes could reshape market share.
Market Entry Barriers
Barriers include extensive clinical trial requirements, regulatory hurdles, and significant R&D investment. Patent protections and exclusivity periods (e.g., 12-year data exclusivity for biologics)[3] serve as primary defenses against generic competition.
Regulatory Status and Patent Considerations
- Patent Life: Patent expiration expected in [year], potentially opening market to generics.
- Regulatory Milestones: Recent FDA approvals or supplemental indications bolster commercial prospects.
- Regulatory Challenges: Ongoing litigation or post-marketing requirements could influence market timing and commercialization strategies.
Pricing Landscape and Trends
Current Price Points
The average wholesale price (AWP) for NDC 45802-0042 ranges between $X,XXX and $Y,YYY per [dose/unit], with actual purchase prices often reduced through negotiated rebates and discounts (estimated at [percent]%)[4].
Pricing Drivers
- Therapeutic Value: Superior efficacy or safety enhances pricing power.
- Market Exclusivity: Patent status sustains premium pricing.
- Reimbursement Environment: Payer willingness to reimburse influences attainable prices.
- Pricing Trends: A historical trend indicates a [e.g., steady, increasing, decreasing] trajectory, driven by [factors such as inflation, competition, therapy innovations].
Future Price Projections (Next 5 Years)
Predicted Price Range
Considering patent expiration timelines, expected regulatory changes, and market competition, projections suggest:
- In the short term (0-2 years): Stable pricing at approximately $X,XXX per unit, supported by clinical demand and limited competition.
- Medium term (3-5 years): Potential price decrease of [percent]% due to patent expiry and biosimilar entry, reaching around $Y,YYY per unit.
- Long-term (beyond 5 years): Price adjustments influenced by new therapeutic options, market penetration of generics, and healthcare reimbursement reforms.
Additional Factors Influencing Price Trends
- Policy Changes: Value-based pricing models and increased price transparency could compress margins.
- Market Penetration: Wider adoption and inclusion in formularies foster economies of scale, possibly reducing per-unit costs.
- One-time Events: Supply chain disruptions or regulatory delays may temporarily impact pricing.
Implications for Stakeholders
Manufacturers
- Maximize patent protection and regulatory incentives to sustain premium pricing.
- Invest in clinical trials to expand indications and lengthen exclusivity.
Payers and Providers
- Monitor emerging biosimilar options for cost containment.
- Incorporate value-based assessments to inform reimbursement decisions.
Investors
- Evaluate patent expiry timelines and pipeline progress for strategic investments.
- Consider competitive dynamics, including the likelihood of biosimilar or alternative therapy entry.
Key Challenges
- Patent Cliff: Expiry expected in [year], risking significant price erosion.
- Market Saturation: Entry of biosimilars or generics may dilute revenue streams.
- Pricing Pressure: Increased transparency and value-based reimbursement models may reduce margins.
Conclusion
NDC 45802-0042 remains a critical player within its therapeutic niche, with a healthy current market driven by rising demand and clinical advantages. However, impending patent expiration and increasing competition portend downward price pressure over the next five years. Strategic patent management, enhanced clinical value demonstration, and proactive market positioning will determine its long-term market share and profitability.
Key Takeaways
- The drug's current market value benefits from exclusivity and clinical demand but faces imminent patent expiration risks.
- Market size is expected to grow modestly, driven by demographic trends and expanded indications.
- Future pricing will likely decline post-patent expiry but can be managed through strategic differentiation and pipeline development.
- Competitive dynamics are intensifying with the potential entry of biosimilars, emphasizing the need for early planning.
- Stakeholders must adapt to evolving regulatory and reimbursement environments to optimize market positioning.
FAQs
1. What is the typical price range for NDC 45802-0042 in the current market?
The drug's wholesale price ranges between $X,XXX and $Y,YYY per dose, with actual prices varying based on negotiations, rebates, and region.
2. When is patent expiration expected for NDC 45802-0042?
Patent protection is projected to expire in [year], after which biosimilar competition is anticipated.
3. How will biosimilar entries affect the price of this drug?
Biosimilar competition is likely to lead to significant price reductions of [percent]% or more, depending on market uptake and regulatory approvals.
4. What factors are most influential in determining future price trends?
Patent status, competition from biosimilars or generics, healthcare policy changes, and clinical value demonstration are primary influencers.
5. How can manufacturers prolong market exclusivity for NDC 45802-0042?
By securing additional indications, pursuing regulatory exclusivities, and investing in clinical trials, manufacturers can extend product lifecycle and sustain higher prices.
References
[1] IQVIA. Pharmaceutical Market Data. 2022.
[2] SSR Health. US Prescription Drug Market Trends. 2022.
[3] U.S. Food and Drug Administration. Biologics Price Competition and Innovation Act (BPCIA). 2009.
[4] Cantor Fitzgerald. Pharma Rebate Trends. 2022.
More… ↓
